Why You Should Typeset Your Papers

Throughout our scientific careers we are continually judged by the way we present our ideas, methods and results. Although it is generally agreed that scientific work should be judged only on its scientific merits, we all know of excellent papers that were poorly presented at a national meeting, and further handicapped by unreadable slides that compromised some exciting ideas. Intuitively, it is almost trivial to assume that not only the content, but also the presentation governs the effect of o

Written byGideon Koren
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In the world of marketing and advertising the package—the choice of graphics, colors, the right title and so forth—has long been recognized to be equally important as the product itself. Scientists, however, are more naive, hoping to be judged only by the quality of their science. If market rules apply also to scientists, then those who ignore them may decrease their chances of survival in this Darwinistic arena.

For the most part, it is impossible to quantify the effect of the way scientific work is presented on its acceptability. Most of us do not have access to the material needed for such analysis, be it grant applications or papers submitted to journals. In the case of abstracts submitted to scientific meetings, most societies publish only those papers accepted for presentation, making comparison with non-accepted papers impossible.

But I think it's important to try to develop some comparisons, so recently I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies